Delivery Order SPE2DR25D3401-SPE2DR26FL0ZZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,002.34 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial with diluents. This contract, awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for Vivitrol 380 mg vial-diluents with a ceiling value of $1,055.07. This is a firm fixed price delivery order with an ultimate completion date of December 10, 2025, and represents a non-competitive award under an existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,110.14 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. The contract is a firm fixed price delivery order with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive award. Performance will occur at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,055.07 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials and diluents. This non-competitive, firm fixed-price delivery order was executed on December 17, 2025, with an ultimate completion date of December 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid and alcohol use disorders, representing part of the Defense Health...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,109.19 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract is a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and was awarded on January 7, 2026. This award was made without set-aside status, indicating it was competitively awarded. The contractor's place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters...
- The Defense Logistics Agency awarded a $3,165.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 22, 2025. This non-set-aside delivery order was issued on December 19, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Vivitrol is a medication used for opioid use disorder treatment and alcohol use disorder, representing the type of specialized pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,327.57 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents. This firm fixed-price contract, awarded on January 8, 2026, with a completion date of January 9, 2026, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be performed at the awardee's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $4,733.15 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents on January 9, 2026, with completion expected by January 12, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. Vivitrol is a medication used in the treatment of opioid dependence and alcohol use disorder, making this procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Vivitrol 380 mg vial-diluents with a ceiling value of $6,330.42. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The contractor will perform from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $5,712.57 delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of December 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0ZZDelivery Order
The Defense Logistics Agency awarded a $2,218.38 firm fixed-price delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 12, 2026, for Vivitrol 380 mg vials with diluents. The contract, which is not set-aside, is scheduled for ultimate completion on January 13, 2026, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task order under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical procurement mechanism for military healthcare systems. Amerisourcebergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery of Vivitrol, a medication used in the treatment of opioid and alcohol use disorders, demonstrates the company's role in supplying specialized pharmaceutical products to support military personnel health and readiness. The non-competitive award status reflects the established relationship under the existing IDC vehicle, enabling the Defense Logistics Agency to efficiently procure essential medications for its global healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/11/26 |